|
Frank, R N; Amin, R H; Puklin, J E (1999) Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration. Am J Ophthalmol 127:694-709
|
|
Frank, R N (1998) ""Oxidative protector"" enzymes in the macular retinal pigment epithelium of aging eyes and eyes with age-related macular degeneration. Trans Am Ophthalmol Soc 96:635-89
|
|
Amin, R H; Frank, R N; Kennedy, A et al. (1997) Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38:36-47
|
|
Frank, R N; Amin, R; Kennedy, A et al. (1997) An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Arch Ophthalmol 115:1036-47
|
|
Frank, R N (1997) Growth factors in age-related macular degeneration: pathogenic and therapeutic implications. Ophthalmic Res 29:341-53
|
|
Frank, R N; Amin, R H; Eliott, D et al. (1996) Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 122:393-403
|
|
Amin, R; Puklin, J E; Frank, R N (1994) Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci 35:3178-88
|
|
Frank, R N (1994) The aldose reductase controversy. Diabetes 43:169-72
|
|
Das, A; Puklin, J E; Frank, R N et al. (1992) Ultrastructural immunocytochemistry of subretinal neovascular membranes in age-related macular degeneration. Ophthalmology 99:1368-76
|
|
Frank, R N (1991) On the pathogenesis of diabetic retinopathy. A 1990 update. Ophthalmology 98:586-93
|
Showing the most recent 10 out of 22 publications
